nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—CYP11B2—coronary artery disease	0.318	1	CbGaD
Metoclopramide—migraine—Acetylsalicylic acid—coronary artery disease	0.278	1	CpDpCtD
Metoclopramide—CYP11B2—Eplerenone—coronary artery disease	0.197	0.808	CbGbCtD
Metoclopramide—CYP2D6—Niacin—coronary artery disease	0.00808	0.0332	CbGbCtD
Metoclopramide—CYP2D6—Timolol—coronary artery disease	0.00751	0.0309	CbGbCtD
Metoclopramide—CYP2D6—Captopril—coronary artery disease	0.00661	0.0272	CbGbCtD
Metoclopramide—CYP2D6—Simvastatin—coronary artery disease	0.00638	0.0262	CbGbCtD
Metoclopramide—CYP2D6—Pravastatin—coronary artery disease	0.00625	0.0257	CbGbCtD
Metoclopramide—CYP2D6—Lovastatin—coronary artery disease	0.00625	0.0257	CbGbCtD
Metoclopramide—CYP2D6—Atorvastatin—coronary artery disease	0.00569	0.0234	CbGbCtD
Metoclopramide—Sunitinib—RPS6KB1—coronary artery disease	0.00039	0.19	CrCbGaD
Metoclopramide—Amisulpride—HTR7—coronary artery disease	0.000354	0.173	CrCbGaD
Metoclopramide—Sunitinib—JAK2—coronary artery disease	0.000323	0.158	CrCbGaD
Metoclopramide—Procainamide—SLC22A3—coronary artery disease	0.000194	0.0948	CrCbGaD
Metoclopramide—Sunitinib—KDR—coronary artery disease	0.000191	0.093	CrCbGaD
Metoclopramide—Sunitinib—KIT—coronary artery disease	0.00018	0.0878	CrCbGaD
Metoclopramide—Amisulpride—HTR2A—coronary artery disease	0.000178	0.0869	CrCbGaD
Metoclopramide—Cisapride—CYP2C19—coronary artery disease	0.000132	0.0643	CrCbGaD
Metoclopramide—Cisapride—HTR2A—coronary artery disease	0.000107	0.0521	CrCbGaD
Metoclopramide—Hypotension—Perindopril—coronary artery disease	7.25e-05	0.000859	CcSEcCtD
Metoclopramide—Insomnia—Captopril—coronary artery disease	7.23e-05	0.000857	CcSEcCtD
Metoclopramide—Fatigue—Trandolapril—coronary artery disease	7.22e-05	0.000855	CcSEcCtD
Metoclopramide—Fatigue—Enalapril—coronary artery disease	7.19e-05	0.000851	CcSEcCtD
Metoclopramide—Asthenia—Ezetimibe—coronary artery disease	7.17e-05	0.00085	CcSEcCtD
Metoclopramide—Tremor—Ramipril—coronary artery disease	7.17e-05	0.000849	CcSEcCtD
Metoclopramide—Urticaria—Valsartan—coronary artery disease	7.15e-05	0.000847	CcSEcCtD
Metoclopramide—Nausea—Rosuvastatin—coronary artery disease	7.14e-05	0.000846	CcSEcCtD
Metoclopramide—Diarrhoea—Fenofibrate—coronary artery disease	7.14e-05	0.000846	CcSEcCtD
Metoclopramide—Dyspnoea—Captopril—coronary artery disease	7.13e-05	0.000844	CcSEcCtD
Metoclopramide—Urticaria—Olmesartan—coronary artery disease	7.12e-05	0.000843	CcSEcCtD
Metoclopramide—Somnolence—Captopril—coronary artery disease	7.11e-05	0.000842	CcSEcCtD
Metoclopramide—Tachycardia—Losartan—coronary artery disease	7.11e-05	0.000842	CcSEcCtD
Metoclopramide—Feeling abnormal—Pravastatin—coronary artery disease	7.1e-05	0.000841	CcSEcCtD
Metoclopramide—Fatigue—Telmisartan—coronary artery disease	7.09e-05	0.00084	CcSEcCtD
Metoclopramide—Body temperature increased—Olmesartan—coronary artery disease	7.08e-05	0.000839	CcSEcCtD
Metoclopramide—Hypotension—Furosemide—coronary artery disease	7.05e-05	0.000835	CcSEcCtD
Metoclopramide—Agitation—Ramipril—coronary artery disease	7.03e-05	0.000833	CcSEcCtD
Metoclopramide—Hypersensitivity—Simvastatin—coronary artery disease	7.02e-05	0.000832	CcSEcCtD
Metoclopramide—Insomnia—Perindopril—coronary artery disease	7.02e-05	0.000832	CcSEcCtD
Metoclopramide—Diarrhoea—Clopidogrel—coronary artery disease	7.02e-05	0.000832	CcSEcCtD
Metoclopramide—Asthenia—Eplerenone—coronary artery disease	7.02e-05	0.000832	CcSEcCtD
Metoclopramide—Angioedema—Ramipril—coronary artery disease	6.99e-05	0.000828	CcSEcCtD
Metoclopramide—Diarrhoea—Lovastatin—coronary artery disease	6.97e-05	0.000826	CcSEcCtD
Metoclopramide—Urticaria—Niacin—coronary artery disease	6.95e-05	0.000824	CcSEcCtD
Metoclopramide—Nausea—Acetylsalicylic acid—coronary artery disease	6.94e-05	0.000822	CcSEcCtD
Metoclopramide—Dyspnoea—Perindopril—coronary artery disease	6.92e-05	0.00082	CcSEcCtD
Metoclopramide—Body temperature increased—Niacin—coronary artery disease	6.92e-05	0.00082	CcSEcCtD
Metoclopramide—Dizziness—Fenofibrate—coronary artery disease	6.9e-05	0.000818	CcSEcCtD
Metoclopramide—Somnolence—Perindopril—coronary artery disease	6.9e-05	0.000817	CcSEcCtD
Metoclopramide—Feeling abnormal—Trandolapril—coronary artery disease	6.9e-05	0.000817	CcSEcCtD
Metoclopramide—Fatigue—Captopril—coronary artery disease	6.89e-05	0.000817	CcSEcCtD
Metoclopramide—Feeling abnormal—Enalapril—coronary artery disease	6.87e-05	0.000814	CcSEcCtD
Metoclopramide—Leukopenia—Ramipril—coronary artery disease	6.85e-05	0.000811	CcSEcCtD
Metoclopramide—Urticaria—Pravastatin—coronary artery disease	6.85e-05	0.000811	CcSEcCtD
Metoclopramide—Asthenia—Simvastatin—coronary artery disease	6.84e-05	0.00081	CcSEcCtD
Metoclopramide—Diarrhoea—Ezetimibe—coronary artery disease	6.84e-05	0.00081	CcSEcCtD
Metoclopramide—Angioedema—Timolol—coronary artery disease	6.83e-05	0.000809	CcSEcCtD
Metoclopramide—Body temperature increased—Pravastatin—coronary artery disease	6.81e-05	0.000807	CcSEcCtD
Metoclopramide—Hypotension—Losartan—coronary artery disease	6.8e-05	0.000806	CcSEcCtD
Metoclopramide—Dizziness—Clopidogrel—coronary artery disease	6.79e-05	0.000804	CcSEcCtD
Metoclopramide—Feeling abnormal—Telmisartan—coronary artery disease	6.78e-05	0.000803	CcSEcCtD
Metoclopramide—Palpitations—Ramipril—coronary artery disease	6.76e-05	0.000801	CcSEcCtD
Metoclopramide—Dizziness—Lovastatin—coronary artery disease	6.74e-05	0.000798	CcSEcCtD
Metoclopramide—Nervousness—Lisinopril—coronary artery disease	6.74e-05	0.000798	CcSEcCtD
Metoclopramide—Somnolence—Furosemide—coronary artery disease	6.71e-05	0.000795	CcSEcCtD
Metoclopramide—Diarrhoea—Eplerenone—coronary artery disease	6.7e-05	0.000793	CcSEcCtD
Metoclopramide—Fatigue—Perindopril—coronary artery disease	6.69e-05	0.000793	CcSEcCtD
Metoclopramide—Muscle spasms—Lisinopril—coronary artery disease	6.67e-05	0.00079	CcSEcCtD
Metoclopramide—Urticaria—Trandolapril—coronary artery disease	6.65e-05	0.000788	CcSEcCtD
Metoclopramide—Hypersensitivity—Valsartan—coronary artery disease	6.63e-05	0.000786	CcSEcCtD
Metoclopramide—Convulsion—Ramipril—coronary artery disease	6.63e-05	0.000785	CcSEcCtD
Metoclopramide—Urticaria—Enalapril—coronary artery disease	6.62e-05	0.000784	CcSEcCtD
Metoclopramide—Body temperature increased—Trandolapril—coronary artery disease	6.62e-05	0.000784	CcSEcCtD
Metoclopramide—Dizziness—Ezetimibe—coronary artery disease	6.61e-05	0.000783	CcSEcCtD
Metoclopramide—Palpitations—Timolol—coronary artery disease	6.61e-05	0.000783	CcSEcCtD
Metoclopramide—Body temperature increased—Enalapril—coronary artery disease	6.59e-05	0.000781	CcSEcCtD
Metoclopramide—Feeling abnormal—Captopril—coronary artery disease	6.59e-05	0.00078	CcSEcCtD
Metoclopramide—Insomnia—Losartan—coronary artery disease	6.59e-05	0.00078	CcSEcCtD
Metoclopramide—Rash—Fenofibrate—coronary artery disease	6.58e-05	0.00078	CcSEcCtD
Metoclopramide—Dermatitis—Fenofibrate—coronary artery disease	6.58e-05	0.000779	CcSEcCtD
Metoclopramide—Headache—Fenofibrate—coronary artery disease	6.54e-05	0.000775	CcSEcCtD
Metoclopramide—Urticaria—Telmisartan—coronary artery disease	6.53e-05	0.000774	CcSEcCtD
Metoclopramide—Diarrhoea—Simvastatin—coronary artery disease	6.52e-05	0.000773	CcSEcCtD
Metoclopramide—Fatigue—Furosemide—coronary artery disease	6.51e-05	0.000771	CcSEcCtD
Metoclopramide—Tremor—Lisinopril—coronary artery disease	6.5e-05	0.00077	CcSEcCtD
Metoclopramide—Body temperature increased—Telmisartan—coronary artery disease	6.5e-05	0.00077	CcSEcCtD
Metoclopramide—Dyspnoea—Losartan—coronary artery disease	6.49e-05	0.000769	CcSEcCtD
Metoclopramide—Anxiety—Ramipril—coronary artery disease	6.49e-05	0.000769	CcSEcCtD
Metoclopramide—Somnolence—Losartan—coronary artery disease	6.47e-05	0.000767	CcSEcCtD
Metoclopramide—Dizziness—Eplerenone—coronary artery disease	6.47e-05	0.000766	CcSEcCtD
Metoclopramide—Rash—Clopidogrel—coronary artery disease	6.47e-05	0.000766	CcSEcCtD
Metoclopramide—Dermatitis—Clopidogrel—coronary artery disease	6.46e-05	0.000766	CcSEcCtD
Metoclopramide—Asthenia—Valsartan—coronary artery disease	6.46e-05	0.000765	CcSEcCtD
Metoclopramide—Hypertension—Timolol—coronary artery disease	6.46e-05	0.000765	CcSEcCtD
Metoclopramide—Hypersensitivity—Niacin—coronary artery disease	6.45e-05	0.000764	CcSEcCtD
Metoclopramide—Asthenia—Olmesartan—coronary artery disease	6.43e-05	0.000761	CcSEcCtD
Metoclopramide—Headache—Clopidogrel—coronary artery disease	6.43e-05	0.000761	CcSEcCtD
Metoclopramide—Rash—Lovastatin—coronary artery disease	6.43e-05	0.000761	CcSEcCtD
Metoclopramide—Dermatitis—Lovastatin—coronary artery disease	6.42e-05	0.000761	CcSEcCtD
Metoclopramide—Feeling abnormal—Perindopril—coronary artery disease	6.4e-05	0.000758	CcSEcCtD
Metoclopramide—Headache—Lovastatin—coronary artery disease	6.39e-05	0.000756	CcSEcCtD
Metoclopramide—Hypersensitivity—Pravastatin—coronary artery disease	6.35e-05	0.000752	CcSEcCtD
Metoclopramide—Anxiety—Timolol—coronary artery disease	6.35e-05	0.000752	CcSEcCtD
Metoclopramide—Angioedema—Lisinopril—coronary artery disease	6.34e-05	0.000751	CcSEcCtD
Metoclopramide—Body temperature increased—Captopril—coronary artery disease	6.32e-05	0.000749	CcSEcCtD
Metoclopramide—Dizziness—Simvastatin—coronary artery disease	6.3e-05	0.000747	CcSEcCtD
Metoclopramide—Rash—Ezetimibe—coronary artery disease	6.3e-05	0.000747	CcSEcCtD
Metoclopramide—Dermatitis—Ezetimibe—coronary artery disease	6.3e-05	0.000746	CcSEcCtD
Metoclopramide—Confusional state—Ramipril—coronary artery disease	6.3e-05	0.000746	CcSEcCtD
Metoclopramide—Asthenia—Niacin—coronary artery disease	6.28e-05	0.000744	CcSEcCtD
Metoclopramide—Fatigue—Losartan—coronary artery disease	6.28e-05	0.000744	CcSEcCtD
Metoclopramide—Headache—Ezetimibe—coronary artery disease	6.26e-05	0.000742	CcSEcCtD
Metoclopramide—Oedema—Ramipril—coronary artery disease	6.24e-05	0.00074	CcSEcCtD
Metoclopramide—Feeling abnormal—Furosemide—coronary artery disease	6.22e-05	0.000737	CcSEcCtD
Metoclopramide—Leukopenia—Lisinopril—coronary artery disease	6.21e-05	0.000736	CcSEcCtD
Metoclopramide—Nausea—Fenofibrate—coronary artery disease	6.2e-05	0.000734	CcSEcCtD
Metoclopramide—Asthenia—Pravastatin—coronary artery disease	6.18e-05	0.000733	CcSEcCtD
Metoclopramide—Rash—Eplerenone—coronary artery disease	6.17e-05	0.000731	CcSEcCtD
Metoclopramide—Urticaria—Perindopril—coronary artery disease	6.17e-05	0.000731	CcSEcCtD
Metoclopramide—Hypersensitivity—Trandolapril—coronary artery disease	6.17e-05	0.00073	CcSEcCtD
Metoclopramide—Dermatitis—Eplerenone—coronary artery disease	6.16e-05	0.00073	CcSEcCtD
Metoclopramide—Diarrhoea—Valsartan—coronary artery disease	6.16e-05	0.00073	CcSEcCtD
Metoclopramide—Confusional state—Timolol—coronary artery disease	6.15e-05	0.000729	CcSEcCtD
Metoclopramide—Hypersensitivity—Enalapril—coronary artery disease	6.14e-05	0.000728	CcSEcCtD
Metoclopramide—Body temperature increased—Perindopril—coronary artery disease	6.14e-05	0.000727	CcSEcCtD
Metoclopramide—Palpitations—Lisinopril—coronary artery disease	6.13e-05	0.000726	CcSEcCtD
Metoclopramide—Diarrhoea—Olmesartan—coronary artery disease	6.13e-05	0.000726	CcSEcCtD
Metoclopramide—Headache—Eplerenone—coronary artery disease	6.13e-05	0.000726	CcSEcCtD
Metoclopramide—Oedema—Timolol—coronary artery disease	6.1e-05	0.000723	CcSEcCtD
Metoclopramide—Nausea—Clopidogrel—coronary artery disease	6.1e-05	0.000722	CcSEcCtD
Metoclopramide—Tachycardia—Ramipril—coronary artery disease	6.09e-05	0.000722	CcSEcCtD
Metoclopramide—Hypersensitivity—Telmisartan—coronary artery disease	6.06e-05	0.000718	CcSEcCtD
Metoclopramide—Nausea—Lovastatin—coronary artery disease	6.05e-05	0.000717	CcSEcCtD
Metoclopramide—Rash—Simvastatin—coronary artery disease	6.01e-05	0.000712	CcSEcCtD
Metoclopramide—Dermatitis—Simvastatin—coronary artery disease	6.01e-05	0.000711	CcSEcCtD
Metoclopramide—Asthenia—Trandolapril—coronary artery disease	6.01e-05	0.000711	CcSEcCtD
Metoclopramide—Feeling abnormal—Losartan—coronary artery disease	6e-05	0.000711	CcSEcCtD
Metoclopramide—Urticaria—Furosemide—coronary artery disease	6e-05	0.00071	CcSEcCtD
Metoclopramide—Diarrhoea—Niacin—coronary artery disease	5.99e-05	0.000709	CcSEcCtD
Metoclopramide—Asthenia—Enalapril—coronary artery disease	5.98e-05	0.000708	CcSEcCtD
Metoclopramide—Headache—Simvastatin—coronary artery disease	5.97e-05	0.000707	CcSEcCtD
Metoclopramide—Body temperature increased—Furosemide—coronary artery disease	5.97e-05	0.000707	CcSEcCtD
Metoclopramide—Dizziness—Valsartan—coronary artery disease	5.95e-05	0.000705	CcSEcCtD
Metoclopramide—Nausea—Ezetimibe—coronary artery disease	5.94e-05	0.000703	CcSEcCtD
Metoclopramide—Dizziness—Olmesartan—coronary artery disease	5.93e-05	0.000702	CcSEcCtD
Metoclopramide—Asthenia—Telmisartan—coronary artery disease	5.9e-05	0.000699	CcSEcCtD
Metoclopramide—Diarrhoea—Pravastatin—coronary artery disease	5.9e-05	0.000699	CcSEcCtD
Metoclopramide—Anxiety—Lisinopril—coronary artery disease	5.89e-05	0.000697	CcSEcCtD
Metoclopramide—Hypotension—Ramipril—coronary artery disease	5.83e-05	0.000691	CcSEcCtD
Metoclopramide—Nausea—Eplerenone—coronary artery disease	5.81e-05	0.000688	CcSEcCtD
Metoclopramide—Dizziness—Niacin—coronary artery disease	5.79e-05	0.000686	CcSEcCtD
Metoclopramide—Urticaria—Losartan—coronary artery disease	5.79e-05	0.000685	CcSEcCtD
Metoclopramide—Body temperature increased—Losartan—coronary artery disease	5.76e-05	0.000682	CcSEcCtD
Metoclopramide—Asthenia—Captopril—coronary artery disease	5.74e-05	0.00068	CcSEcCtD
Metoclopramide—Diarrhoea—Trandolapril—coronary artery disease	5.73e-05	0.000678	CcSEcCtD
Metoclopramide—Confusional state—Lisinopril—coronary artery disease	5.71e-05	0.000676	CcSEcCtD
Metoclopramide—Diarrhoea—Enalapril—coronary artery disease	5.7e-05	0.000676	CcSEcCtD
Metoclopramide—Hypotension—Timolol—coronary artery disease	5.7e-05	0.000676	CcSEcCtD
Metoclopramide—Dizziness—Pravastatin—coronary artery disease	5.7e-05	0.000675	CcSEcCtD
Metoclopramide—Rash—Valsartan—coronary artery disease	5.68e-05	0.000672	CcSEcCtD
Metoclopramide—Dermatitis—Valsartan—coronary artery disease	5.67e-05	0.000672	CcSEcCtD
Metoclopramide—Nausea—Simvastatin—coronary artery disease	5.66e-05	0.000671	CcSEcCtD
Metoclopramide—Oedema—Lisinopril—coronary artery disease	5.66e-05	0.000671	CcSEcCtD
Metoclopramide—Rash—Olmesartan—coronary artery disease	5.65e-05	0.000669	CcSEcCtD
Metoclopramide—Insomnia—Ramipril—coronary artery disease	5.65e-05	0.000669	CcSEcCtD
Metoclopramide—Dermatitis—Olmesartan—coronary artery disease	5.64e-05	0.000669	CcSEcCtD
Metoclopramide—Headache—Valsartan—coronary artery disease	5.64e-05	0.000668	CcSEcCtD
Metoclopramide—Diarrhoea—Telmisartan—coronary artery disease	5.63e-05	0.000666	CcSEcCtD
Metoclopramide—Headache—Olmesartan—coronary artery disease	5.61e-05	0.000665	CcSEcCtD
Metoclopramide—Asthenia—Perindopril—coronary artery disease	5.57e-05	0.00066	CcSEcCtD
Metoclopramide—Dyspnoea—Ramipril—coronary artery disease	5.57e-05	0.000659	CcSEcCtD
Metoclopramide—Hypersensitivity—Furosemide—coronary artery disease	5.56e-05	0.000659	CcSEcCtD
Metoclopramide—Somnolence—Ramipril—coronary artery disease	5.55e-05	0.000657	CcSEcCtD
Metoclopramide—Dizziness—Trandolapril—coronary artery disease	5.54e-05	0.000656	CcSEcCtD
Metoclopramide—Tachycardia—Lisinopril—coronary artery disease	5.53e-05	0.000655	CcSEcCtD
Metoclopramide—Insomnia—Timolol—coronary artery disease	5.52e-05	0.000654	CcSEcCtD
Metoclopramide—Rash—Niacin—coronary artery disease	5.52e-05	0.000654	CcSEcCtD
Metoclopramide—Dermatitis—Niacin—coronary artery disease	5.51e-05	0.000653	CcSEcCtD
Metoclopramide—Dizziness—Enalapril—coronary artery disease	5.51e-05	0.000653	CcSEcCtD
Metoclopramide—Headache—Niacin—coronary artery disease	5.48e-05	0.00065	CcSEcCtD
Metoclopramide—Diarrhoea—Captopril—coronary artery disease	5.47e-05	0.000648	CcSEcCtD
Metoclopramide—Dyspnoea—Timolol—coronary artery disease	5.44e-05	0.000645	CcSEcCtD
Metoclopramide—Dizziness—Telmisartan—coronary artery disease	5.44e-05	0.000644	CcSEcCtD
Metoclopramide—Rash—Pravastatin—coronary artery disease	5.43e-05	0.000644	CcSEcCtD
Metoclopramide—Dermatitis—Pravastatin—coronary artery disease	5.43e-05	0.000643	CcSEcCtD
Metoclopramide—Somnolence—Timolol—coronary artery disease	5.43e-05	0.000643	CcSEcCtD
Metoclopramide—Asthenia—Furosemide—coronary artery disease	5.42e-05	0.000641	CcSEcCtD
Metoclopramide—Headache—Pravastatin—coronary artery disease	5.4e-05	0.00064	CcSEcCtD
Metoclopramide—Fatigue—Ramipril—coronary artery disease	5.38e-05	0.000638	CcSEcCtD
Metoclopramide—Hypersensitivity—Losartan—coronary artery disease	5.37e-05	0.000635	CcSEcCtD
Metoclopramide—Nausea—Valsartan—coronary artery disease	5.35e-05	0.000633	CcSEcCtD
Metoclopramide—Nausea—Olmesartan—coronary artery disease	5.32e-05	0.00063	CcSEcCtD
Metoclopramide—Diarrhoea—Perindopril—coronary artery disease	5.31e-05	0.000629	CcSEcCtD
Metoclopramide—Hypotension—Lisinopril—coronary artery disease	5.29e-05	0.000627	CcSEcCtD
Metoclopramide—Dizziness—Captopril—coronary artery disease	5.29e-05	0.000626	CcSEcCtD
Metoclopramide—Rash—Trandolapril—coronary artery disease	5.28e-05	0.000625	CcSEcCtD
Metoclopramide—Dermatitis—Trandolapril—coronary artery disease	5.27e-05	0.000625	CcSEcCtD
Metoclopramide—Fatigue—Timolol—coronary artery disease	5.26e-05	0.000623	CcSEcCtD
Metoclopramide—Rash—Enalapril—coronary artery disease	5.26e-05	0.000623	CcSEcCtD
Metoclopramide—Dermatitis—Enalapril—coronary artery disease	5.25e-05	0.000622	CcSEcCtD
Metoclopramide—Headache—Trandolapril—coronary artery disease	5.24e-05	0.000621	CcSEcCtD
Metoclopramide—Asthenia—Losartan—coronary artery disease	5.22e-05	0.000619	CcSEcCtD
Metoclopramide—Headache—Enalapril—coronary artery disease	5.22e-05	0.000619	CcSEcCtD
Metoclopramide—Nausea—Niacin—coronary artery disease	5.2e-05	0.000616	CcSEcCtD
Metoclopramide—Rash—Telmisartan—coronary artery disease	5.18e-05	0.000614	CcSEcCtD
Metoclopramide—Dermatitis—Telmisartan—coronary artery disease	5.18e-05	0.000614	CcSEcCtD
Metoclopramide—Diarrhoea—Furosemide—coronary artery disease	5.16e-05	0.000612	CcSEcCtD
Metoclopramide—Headache—Telmisartan—coronary artery disease	5.15e-05	0.00061	CcSEcCtD
Metoclopramide—Feeling abnormal—Ramipril—coronary artery disease	5.15e-05	0.000609	CcSEcCtD
Metoclopramide—Dizziness—Perindopril—coronary artery disease	5.13e-05	0.000608	CcSEcCtD
Metoclopramide—Insomnia—Lisinopril—coronary artery disease	5.12e-05	0.000607	CcSEcCtD
Metoclopramide—Nausea—Pravastatin—coronary artery disease	5.12e-05	0.000606	CcSEcCtD
Metoclopramide—Dyspnoea—Lisinopril—coronary artery disease	5.05e-05	0.000598	CcSEcCtD
Metoclopramide—Rash—Captopril—coronary artery disease	5.04e-05	0.000597	CcSEcCtD
Metoclopramide—Dermatitis—Captopril—coronary artery disease	5.04e-05	0.000597	CcSEcCtD
Metoclopramide—Somnolence—Lisinopril—coronary artery disease	5.03e-05	0.000596	CcSEcCtD
Metoclopramide—Feeling abnormal—Timolol—coronary artery disease	5.03e-05	0.000596	CcSEcCtD
Metoclopramide—Headache—Captopril—coronary artery disease	5.01e-05	0.000593	CcSEcCtD
Metoclopramide—Dizziness—Furosemide—coronary artery disease	4.99e-05	0.000591	CcSEcCtD
Metoclopramide—Diarrhoea—Losartan—coronary artery disease	4.98e-05	0.00059	CcSEcCtD
Metoclopramide—Nausea—Trandolapril—coronary artery disease	4.97e-05	0.000589	CcSEcCtD
Metoclopramide—Urticaria—Ramipril—coronary artery disease	4.96e-05	0.000588	CcSEcCtD
Metoclopramide—Nausea—Enalapril—coronary artery disease	4.95e-05	0.000587	CcSEcCtD
Metoclopramide—Body temperature increased—Ramipril—coronary artery disease	4.94e-05	0.000585	CcSEcCtD
Metoclopramide—Rash—Perindopril—coronary artery disease	4.9e-05	0.00058	CcSEcCtD
Metoclopramide—Dermatitis—Perindopril—coronary artery disease	4.89e-05	0.000579	CcSEcCtD
Metoclopramide—Nausea—Telmisartan—coronary artery disease	4.88e-05	0.000579	CcSEcCtD
Metoclopramide—Fatigue—Lisinopril—coronary artery disease	4.88e-05	0.000578	CcSEcCtD
Metoclopramide—Headache—Perindopril—coronary artery disease	4.86e-05	0.000576	CcSEcCtD
Metoclopramide—Urticaria—Timolol—coronary artery disease	4.85e-05	0.000574	CcSEcCtD
Metoclopramide—Body temperature increased—Timolol—coronary artery disease	4.83e-05	0.000572	CcSEcCtD
Metoclopramide—Dizziness—Losartan—coronary artery disease	4.82e-05	0.00057	CcSEcCtD
Metoclopramide—Rash—Furosemide—coronary artery disease	4.76e-05	0.000564	CcSEcCtD
Metoclopramide—Dermatitis—Furosemide—coronary artery disease	4.75e-05	0.000563	CcSEcCtD
Metoclopramide—Nausea—Captopril—coronary artery disease	4.75e-05	0.000563	CcSEcCtD
Metoclopramide—Headache—Furosemide—coronary artery disease	4.73e-05	0.00056	CcSEcCtD
Metoclopramide—Feeling abnormal—Lisinopril—coronary artery disease	4.67e-05	0.000553	CcSEcCtD
Metoclopramide—Nausea—Perindopril—coronary artery disease	4.61e-05	0.000546	CcSEcCtD
Metoclopramide—Hypersensitivity—Ramipril—coronary artery disease	4.6e-05	0.000545	CcSEcCtD
Metoclopramide—Rash—Losartan—coronary artery disease	4.59e-05	0.000544	CcSEcCtD
Metoclopramide—Dermatitis—Losartan—coronary artery disease	4.59e-05	0.000543	CcSEcCtD
Metoclopramide—Headache—Losartan—coronary artery disease	4.56e-05	0.00054	CcSEcCtD
Metoclopramide—Urticaria—Lisinopril—coronary artery disease	4.5e-05	0.000533	CcSEcCtD
Metoclopramide—Hypersensitivity—Timolol—coronary artery disease	4.5e-05	0.000533	CcSEcCtD
Metoclopramide—Nausea—Furosemide—coronary artery disease	4.48e-05	0.000531	CcSEcCtD
Metoclopramide—Asthenia—Ramipril—coronary artery disease	4.48e-05	0.000531	CcSEcCtD
Metoclopramide—Body temperature increased—Lisinopril—coronary artery disease	4.48e-05	0.00053	CcSEcCtD
Metoclopramide—Asthenia—Timolol—coronary artery disease	4.38e-05	0.000519	CcSEcCtD
Metoclopramide—Nausea—Losartan—coronary artery disease	4.33e-05	0.000512	CcSEcCtD
Metoclopramide—Diarrhoea—Ramipril—coronary artery disease	4.27e-05	0.000506	CcSEcCtD
Metoclopramide—Diarrhoea—Timolol—coronary artery disease	4.18e-05	0.000495	CcSEcCtD
Metoclopramide—Hypersensitivity—Lisinopril—coronary artery disease	4.17e-05	0.000494	CcSEcCtD
Metoclopramide—Dizziness—Ramipril—coronary artery disease	4.13e-05	0.000489	CcSEcCtD
Metoclopramide—Asthenia—Lisinopril—coronary artery disease	4.06e-05	0.000481	CcSEcCtD
Metoclopramide—Dizziness—Timolol—coronary artery disease	4.04e-05	0.000478	CcSEcCtD
Metoclopramide—Rash—Ramipril—coronary artery disease	3.94e-05	0.000466	CcSEcCtD
Metoclopramide—Dermatitis—Ramipril—coronary artery disease	3.93e-05	0.000466	CcSEcCtD
Metoclopramide—Headache—Ramipril—coronary artery disease	3.91e-05	0.000463	CcSEcCtD
Metoclopramide—Diarrhoea—Lisinopril—coronary artery disease	3.87e-05	0.000459	CcSEcCtD
Metoclopramide—Rash—Timolol—coronary artery disease	3.85e-05	0.000456	CcSEcCtD
Metoclopramide—Dermatitis—Timolol—coronary artery disease	3.85e-05	0.000455	CcSEcCtD
Metoclopramide—Headache—Timolol—coronary artery disease	3.82e-05	0.000453	CcSEcCtD
Metoclopramide—Dizziness—Lisinopril—coronary artery disease	3.74e-05	0.000444	CcSEcCtD
Metoclopramide—Nausea—Ramipril—coronary artery disease	3.71e-05	0.000439	CcSEcCtD
Metoclopramide—Nausea—Timolol—coronary artery disease	3.63e-05	0.000429	CcSEcCtD
Metoclopramide—Rash—Lisinopril—coronary artery disease	3.57e-05	0.000423	CcSEcCtD
Metoclopramide—Dermatitis—Lisinopril—coronary artery disease	3.57e-05	0.000423	CcSEcCtD
Metoclopramide—Headache—Lisinopril—coronary artery disease	3.55e-05	0.00042	CcSEcCtD
Metoclopramide—Nausea—Lisinopril—coronary artery disease	3.36e-05	0.000398	CcSEcCtD
Metoclopramide—DRD2—Signaling Pathways—HTR7—coronary artery disease	2.8e-06	3.75e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PLCB1—coronary artery disease	2.8e-06	3.75e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—PIK3CA—coronary artery disease	2.75e-06	3.68e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ITGB3—coronary artery disease	2.75e-06	3.67e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR7—coronary artery disease	2.74e-06	3.67e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—VCAN—coronary artery disease	2.72e-06	3.64e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALDOA—coronary artery disease	2.7e-06	3.62e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCL8—coronary artery disease	2.68e-06	3.59e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ITGAV—coronary artery disease	2.67e-06	3.57e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PPP2CA—coronary artery disease	2.67e-06	3.57e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—KNG1—coronary artery disease	2.66e-06	3.56e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—POMC—coronary artery disease	2.65e-06	3.55e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CREB1—coronary artery disease	2.65e-06	3.55e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AGTR1—coronary artery disease	2.65e-06	3.54e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—DCN—coronary artery disease	2.62e-06	3.51e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRKCD—coronary artery disease	2.62e-06	3.51e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ITGAV—coronary artery disease	2.61e-06	3.5e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—KNG1—coronary artery disease	2.6e-06	3.48e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—POMC—coronary artery disease	2.6e-06	3.47e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CREB1—coronary artery disease	2.6e-06	3.47e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL2—coronary artery disease	2.6e-06	3.47e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AGTR1—coronary artery disease	2.59e-06	3.46e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6R—coronary artery disease	2.59e-06	3.46e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL10—coronary artery disease	2.59e-06	3.46e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PLG—coronary artery disease	2.58e-06	3.45e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—coronary artery disease	2.56e-06	3.43e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—C3—coronary artery disease	2.56e-06	3.43e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALDH2—coronary artery disease	2.55e-06	3.42e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL2—coronary artery disease	2.54e-06	3.4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6R—coronary artery disease	2.53e-06	3.39e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL10—coronary artery disease	2.53e-06	3.39e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PLG—coronary artery disease	2.52e-06	3.38e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADRB2—coronary artery disease	2.51e-06	3.36e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HBA1—coronary artery disease	2.49e-06	3.33e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—LIPC—coronary artery disease	2.49e-06	3.33e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	2.49e-06	3.33e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP2C19—coronary artery disease	2.49e-06	3.33e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRKCE—coronary artery disease	2.48e-06	3.32e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—JAK2—coronary artery disease	2.48e-06	3.31e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOC3—coronary artery disease	2.47e-06	3.31e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SOCS1—coronary artery disease	2.47e-06	3.31e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—S100B—coronary artery disease	2.47e-06	3.3e-05	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PIK3CA—coronary artery disease	2.46e-06	3.29e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—LDLR—coronary artery disease	2.46e-06	3.29e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	2.46e-06	3.29e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HIF1A—coronary artery disease	2.44e-06	3.27e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SOCS3—coronary artery disease	2.44e-06	3.27e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—coronary artery disease	2.44e-06	3.26e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AGT—coronary artery disease	2.43e-06	3.26e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTT1—coronary artery disease	2.43e-06	3.25e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SLC9A1—coronary artery disease	2.43e-06	3.25e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	2.43e-06	3.24e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	2.42e-06	3.24e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	2.42e-06	3.24e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—S100B—coronary artery disease	2.41e-06	3.23e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFBR2—coronary artery disease	2.41e-06	3.23e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—KITLG—coronary artery disease	2.41e-06	3.23e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CETP—coronary artery disease	2.4e-06	3.21e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GCLC—coronary artery disease	2.4e-06	3.21e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	2.39e-06	3.2e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—LEP—coronary artery disease	2.38e-06	3.19e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOE—coronary artery disease	2.38e-06	3.19e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SDC1—coronary artery disease	2.37e-06	3.18e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	2.36e-06	3.16e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—KITLG—coronary artery disease	2.36e-06	3.16e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP3—coronary artery disease	2.36e-06	3.15e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STAT5A—coronary artery disease	2.36e-06	3.15e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOA1—coronary artery disease	2.36e-06	3.15e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—KDR—coronary artery disease	2.34e-06	3.12e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAPK14—coronary artery disease	2.32e-06	3.1e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP3—coronary artery disease	2.31e-06	3.09e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	2.31e-06	3.09e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOB—coronary artery disease	2.28e-06	3.05e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ESR1—coronary artery disease	2.28e-06	3.04e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCL8—coronary artery disease	2.26e-06	3.02e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—JAK2—coronary artery disease	2.25e-06	3.01e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FN1—coronary artery disease	2.25e-06	3.01e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—F2—coronary artery disease	2.25e-06	3.01e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AKT1—coronary artery disease	2.25e-06	3.01e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—EDN1—coronary artery disease	2.24e-06	3e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PSMA6—coronary artery disease	2.24e-06	3e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PSMB5—coronary artery disease	2.24e-06	3e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6ST—coronary artery disease	2.24e-06	3e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOB—coronary artery disease	2.23e-06	2.98e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL5—coronary artery disease	2.23e-06	2.98e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NFKBIA—coronary artery disease	2.22e-06	2.97e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	2.21e-06	2.96e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	2.2e-06	2.94e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—EDN1—coronary artery disease	2.2e-06	2.94e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CSF2—coronary artery disease	2.19e-06	2.93e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FGF1—coronary artery disease	2.19e-06	2.93e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CTGF—coronary artery disease	2.19e-06	2.93e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL5—coronary artery disease	2.18e-06	2.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LPL—coronary artery disease	2.18e-06	2.91e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HMGCR—coronary artery disease	2.17e-06	2.9e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GOT2—coronary artery disease	2.17e-06	2.9e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RPS6KB1—coronary artery disease	2.16e-06	2.89e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MEF2C—coronary artery disease	2.16e-06	2.89e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—KIT—coronary artery disease	2.15e-06	2.88e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CSF2—coronary artery disease	2.15e-06	2.87e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FGF1—coronary artery disease	2.15e-06	2.87e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LPL—coronary artery disease	2.13e-06	2.85e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PIK3CA—coronary artery disease	2.12e-06	2.84e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	2.11e-06	2.82e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	2.11e-06	2.82e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ITGB3—coronary artery disease	2.1e-06	2.81e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—GSK3B—coronary artery disease	2.06e-06	2.76e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	2.06e-06	2.75e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL8—coronary artery disease	2.05e-06	2.75e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CREB1—coronary artery disease	2.05e-06	2.74e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—POMC—coronary artery disease	2.05e-06	2.74e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PPP2CA—coronary artery disease	2.04e-06	2.73e-05	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—AKT1—coronary artery disease	2.01e-06	2.69e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	2.01e-06	2.69e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRKCD—coronary artery disease	2.01e-06	2.68e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL2—coronary artery disease	2e-06	2.68e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	2e-06	2.67e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6R—coronary artery disease	2e-06	2.67e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PLCB1—coronary artery disease	2e-06	2.67e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PIK3CA—coronary artery disease	1.98e-06	2.65e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IGF1—coronary artery disease	1.97e-06	2.64e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	1.96e-06	2.63e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—coronary artery disease	1.96e-06	2.63e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—MAPK1—coronary artery disease	1.96e-06	2.62e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—C3—coronary artery disease	1.96e-06	2.62e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCA1—coronary artery disease	1.93e-06	2.59e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	1.92e-06	2.57e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—C3—coronary artery disease	1.92e-06	2.57e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GGT1—coronary artery disease	1.87e-06	2.51e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GOT1—coronary artery disease	1.87e-06	2.51e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PIK3CA—coronary artery disease	1.87e-06	2.51e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SERPINE1—coronary artery disease	1.87e-06	2.5e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HIF1A—coronary artery disease	1.87e-06	2.5e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AGT—coronary artery disease	1.86e-06	2.49e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	1.83e-06	2.45e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—LEP—coronary artery disease	1.82e-06	2.44e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOE—coronary artery disease	1.82e-06	2.44e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AGT—coronary artery disease	1.82e-06	2.44e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FGF2—coronary artery disease	1.81e-06	2.42e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOA1—coronary artery disease	1.8e-06	2.41e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—KDR—coronary artery disease	1.79e-06	2.39e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NOS3—coronary artery disease	1.79e-06	2.39e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—LEP—coronary artery disease	1.79e-06	2.39e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOE—coronary artery disease	1.79e-06	2.39e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAPK14—coronary artery disease	1.78e-06	2.38e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOA1—coronary artery disease	1.76e-06	2.36e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—KDR—coronary artery disease	1.75e-06	2.34e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ESR1—coronary artery disease	1.74e-06	2.33e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	1.74e-06	2.32e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—JAK2—coronary artery disease	1.74e-06	2.32e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—AKT1—coronary artery disease	1.73e-06	2.32e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—F2—coronary artery disease	1.72e-06	2.3e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FN1—coronary artery disease	1.72e-06	2.3e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6ST—coronary artery disease	1.71e-06	2.29e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ESR1—coronary artery disease	1.7e-06	2.28e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PIK3CA—coronary artery disease	1.7e-06	2.28e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	1.7e-06	2.27e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—F2—coronary artery disease	1.68e-06	2.25e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FN1—coronary artery disease	1.68e-06	2.25e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.68e-06	2.25e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	1.68e-06	2.24e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.67e-06	2.23e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	1.66e-06	2.23e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.66e-06	2.22e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—KIT—coronary artery disease	1.65e-06	2.2e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CAT—coronary artery disease	1.64e-06	2.19e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—AKT1—coronary artery disease	1.62e-06	2.17e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—KIT—coronary artery disease	1.61e-06	2.16e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOB—coronary artery disease	1.59e-06	2.13e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL8—coronary artery disease	1.58e-06	2.12e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GSK3B—coronary artery disease	1.58e-06	2.11e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CREB1—coronary artery disease	1.57e-06	2.1e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—POMC—coronary artery disease	1.57e-06	2.1e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.55e-06	2.07e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	1.55e-06	2.07e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—POMC—coronary artery disease	1.53e-06	2.05e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CREB1—coronary artery disease	1.53e-06	2.05e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL2—coronary artery disease	1.53e-06	2.05e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AKT1—coronary artery disease	1.53e-06	2.05e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6R—coronary artery disease	1.53e-06	2.05e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—LPL—coronary artery disease	1.52e-06	2.03e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CASP3—coronary artery disease	1.52e-06	2.03e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IGF1—coronary artery disease	1.51e-06	2.02e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—coronary artery disease	1.51e-06	2.02e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL2—coronary artery disease	1.5e-06	2.01e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	1.5e-06	2.01e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6R—coronary artery disease	1.5e-06	2e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GPX1—coronary artery disease	1.48e-06	1.98e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCND1—coronary artery disease	1.48e-06	1.97e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IGF1—coronary artery disease	1.48e-06	1.97e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	1.47e-06	1.96e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CD36—coronary artery disease	1.44e-06	1.93e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.43e-06	1.92e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP9—coronary artery disease	1.43e-06	1.92e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	1.43e-06	1.92e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.42e-06	1.91e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.4e-06	1.88e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	1.4e-06	1.87e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AKT1—coronary artery disease	1.39e-06	1.86e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.39e-06	1.85e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.37e-06	1.83e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.37e-06	1.83e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FGF2—coronary artery disease	1.36e-06	1.81e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NOS3—coronary artery disease	1.34e-06	1.79e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.33e-06	1.78e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.3e-06	1.74e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—JAK2—coronary artery disease	1.3e-06	1.74e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AGT—coronary artery disease	1.3e-06	1.74e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VEGFA—coronary artery disease	1.29e-06	1.72e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.27e-06	1.7e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOE—coronary artery disease	1.27e-06	1.7e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOA1—coronary artery disease	1.26e-06	1.68e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.21e-06	1.62e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	1.19e-06	1.59e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TGFB1—coronary artery disease	1.18e-06	1.58e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.17e-06	1.57e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.16e-06	1.55e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAPK1—coronary artery disease	1.16e-06	1.55e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.15e-06	1.54e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.15e-06	1.53e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CASP3—coronary artery disease	1.14e-06	1.52e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.13e-06	1.51e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—coronary artery disease	1.13e-06	1.51e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARG—coronary artery disease	1.11e-06	1.48e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCND1—coronary artery disease	1.11e-06	1.48e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.1e-06	1.47e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—POMC—coronary artery disease	1.09e-06	1.46e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.07e-06	1.44e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.06e-06	1.42e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.04e-06	1.39e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	1e-06	1.34e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALB—coronary artery disease	9.97e-07	1.33e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VEGFA—coronary artery disease	9.85e-07	1.32e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	9.64e-07	1.29e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—NOS3—coronary artery disease	9.53e-07	1.28e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TGFB1—coronary artery disease	9.04e-07	1.21e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—coronary artery disease	8.9e-07	1.19e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAPK1—coronary artery disease	8.86e-07	1.19e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	8.84e-07	1.18e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—coronary artery disease	8.72e-07	1.17e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	8.67e-07	1.16e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AKT1—coronary artery disease	8.21e-07	1.1e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	7.69e-07	1.03e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	7.53e-07	1.01e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—coronary artery disease	6.81e-07	9.11e-06	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—coronary artery disease	6.66e-07	8.92e-06	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AKT1—coronary artery disease	6.28e-07	8.4e-06	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AKT1—coronary artery disease	6.15e-07	8.23e-06	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PIK3CA—coronary artery disease	5.36e-07	7.18e-06	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AKT1—coronary artery disease	4.38e-07	5.86e-06	CbGpPWpGaD
